Fundamentals-based quality & risk · not a recommendation
Zydus Wellness Ltd scores 47/100 (Caution) on the Orion Score — weak business quality (33), moderate growth (58), strong balance-sheet safety (82) and rich valuation (27). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
82/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹1,476.1 | ₹162 | 14.2% | ₹5.09 |
| Q3 2026 | ₹963.3 | ₹-39.9 | 0.5% | ₹-1.25 |
| Q1 2026 | ₹857.7 | ₹127.9 | 16.9% | ₹4.02 |
| Q4 2025 | ₹910.6 | ₹171.9 | 19.5% | ₹5.40 |
| Q3 2025 | ₹450.8 | ₹6.4 | 2.1% | ₹0.20 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2025 | ₹2,691.2 | ₹346.9 | ₹398.8 | 30.7% |
| FY 2024 | ₹2,315.2 | ₹266.9 | ₹307.6 | 12.3% |
| FY 2023 | ₹2,242.6 | ₹310.4 | ₹331.7 | 13.9% |
| FY 2022 | ₹1,988.46 | ₹308.87 | ₹354.75 | 16.1% |
Top companies in the same sector by market cap
| Company | Mkt Cap | P/E | ROCE | ROE | D/E | OPM |
|---|---|---|---|---|---|---|
| ZYDUSWELL ★ | ₹16,054 Cr | 81.26 | 3.71% | 3.43% | 0.55x | 14.23% |
| HINDUNILVR | ₹4,98,466 Cr | 46.95 | 21.37% | 21.60% | 0.03x | 21.55% |
| BRITANNIA | ₹1,30,370 Cr | 51.47 | 57.77% | 53.31% | 0.27x | 16.38% |
| COLPAL | ₹55,550 Cr | 40.99 | 103.69% | 81.59% | 0.03x | 29.98% |
| AWL | ₹24,400 Cr | 23.44 | 15.16% | 10.52% | 0.11x | 1.84% |
| CCL | ₹15,885 Cr | 41.00 | 20.46% | 18.00% | 0.56x | 12.36% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹6,441.9 | ₹6,148.4 | ₹5,833.1 | ₹5,692.18 |
| Equity | ₹5,671.6 | ₹5,357.5 | ₹5,122.6 | ₹4,844.03 |
| Total Debt | ₹188.3 | ₹328.7 | ₹297.3 | ₹387.34 |
| Cash | ₹66.7 | ₹80 | ₹37 | ₹115.38 |
| Net Debt | ₹118.3 | ₹244 | ₹255.5 | ₹266.12 |
| Working Capital | ₹358.7 | ₹444.9 | ₹215.4 | ₹46.89 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 69.84% ↑ | 10.89% ↑ | 8.91% ↓ | 10.36% ↑ |
| Q3 FY2026 | 69.64% | 3.27% ↓ | 18.58% ↓ | 8.51% ↑ |
| Q2 FY2026 | 69.64% | 3.43% ↑ | 18.76% ↓ | 8.18% ↑ |
| Q1 FY2026 | 69.64% | 3.25% ↓ | 19.27% ↓ | 7.83% ↑ |
| Q4 FY2025 | 69.64% ↑ | 3.29% ↓ | 19.76% ↓ | 7.3% ↑ |
| Q3 FY2025 | 69.62% | 3.37% ↑ | 20.12% ↓ | 6.89% ↑ |
| Q2 FY2025 | 69.62% | 3.36% ↑ | 20.37% ↑ | 6.67% ↓ |
| Q1 FY2025 | 69.62% | 3.29% | 19.44% | 7.65% |
| Ex-Date | Action | Details |
|---|---|---|
| 2026-07-17 | DIVIDEND | Dividend - Re 1.20 Per Share |
50 mutual fund schemes
Ask: "Is Zydus Wellness Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.
Zydus Wellness Ltd is listed on the NSE under the Fast Moving Consumer Goods sector, Packaged Foods industry. ISIN: INE768C01028. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.